Our patient did not show any AE over more than one year of treatment with empagliflozin
Men: Erectile Dysfunction Women: HSDD (Hypoactive Sexual Desire Disorder) and FSAD (Female Sexual Arousal Disorder) Improved Libido and Sexual Performance Increase Sexual Desire Longer Duration of Action Boosts metabolism and helps the body burn fat more efficiently
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated With GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus
Patients typically experience 35-50% total body weight loss with bariatric surgery and can continue to enjoy a wide variety of foods
Its primary role is to protect cells from damage caused by free radicals, toxins, and heavy metals
Based on Phase 2 trial data (Jastreboff et al., NEJM 2023), retatrutide's side effect profile appears broadly consistent with other GLP-1-based therapies, though the addition of glucagon receptor agonism introduces some distinct considerations